• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Metrion Biosciences, Venomtech partner

Metrion Biosciences, Venomtech partner

April 24, 2017
CenterWatch Staff

Metrion Biosciences, a specialist ion channel CRO and drug discovery company, and Venomtech, a U.K. biotechnology company with a venom library, announced a collaboration agreement that will see the two companies combine their resources and expertise to search for novel ion channel modulators for use in drug discovery research.

By combining the expertise and screening capabilities of Metrion with Venomtech’s diverse venom collection, knowledge of venom-based drug discovery, hit prioritization and bio-guided fractionation capability, this partnership aims to identify, and rapidly exploit, novel tools for ion channel drug discovery research.  

Venoms are well proven sources of potent and selective ion channel modulators, and have provided the foundation for many ion channel drug discovery programs to date.  Metrion will screen a targeted selection of Venomtech’s venom library against a panel of prioritized ion channel targets to search for, identify and characterize new ion channel modulators and binding sites. Venomtech will use phylogenetic and geographical diversity analysis to design and build a targeted venom discovery array.

Dr. Andrew Southan, head of Commercial Operations at Metrion Biosciences, said, “The Metrion team is very pleased to add Venomtech to our network of collaborators. Via this partnership we can rapidly explore the UK’s largest venom collection for novel pharmacological tools for use in ion channel assay development, validation and drug discovery research. The results of this partnership could significantly boost the chances of successful drug discovery against our prioritized ion channel targets, and Metrion is looking forward to a highly productive working relationship.”

Steve Trim, founder and managing director, Venomtech, commented: “This is a fantastic opportunity to combine our knowledge and expertise in venom-based drug discovery with the great team at Metrion and their electrophysiology excellence. This combination of skills is set to solve many of the challenges of getting good drugs for ion channel targets.”

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing